Clinical Trial Update: Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating cisplatin with either pemetrexed (Alimta) or gemcitabine in a long infusion for malignant mesothel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Alimta (pemetrexed)
• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Mesothelioma | Phase 2 | Status: UNKNOWN